The Health Insurance Review Agency announced that of 1,542 bioequivalence-tested items for the first half, 1,127 have been added to the incentive list of low-priced, substitution-dispensing drugs.
It added that the actual number stood at 1,074 items, as 53 items contain a single ingredient and that 312 items were added to the list compared with 815 items in May. The list also excludes 415 no...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.